๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Serum-soluble Fas level determines clinical symptoms and outcome of patients with aggressive non-Hodgkin's lymphoma

โœ Scribed by Takeshi Hara; Hisashi Tsurumi; Masao Takemura; Hideko Goto; Toshiki Yamada; Michio Sawada; Takeshi Takahashi; Hisataka Moriwaki


Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
75 KB
Volume
64
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Soluble fas in the serum of patients wit
โœ Yufu, Yuji; Choi, Ilseung; Hirase, Nobuhisa; Tokoro, Akihiro; Noguchi, Yumi; Got ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 25 KB ๐Ÿ‘ 2 views

The soluble form of Fas (sFas) can block apoptosis induced by the Fas ligand in vitro. A recent report demonstrated that mice injected with sFas displayed autoimmune features. Therefore, an elevated serum concentration of sFas may be associated with lymphoproliferation and autoimmune diseases. We me

Serum CA 125 is of clinical value in the
โœ Ikram A. Burney; Tariq Siddiqui; Imran Siddiqui ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 30 KB ๐Ÿ‘ 2 views

W e read with interest the article published in Cancer earlier this year regarding the elevation of CA 125 in patients with non-Hodgkin's lymphoma and its normalization with clinical response. 1 Earlier a case report had also emerged about elevation of CA 125 in a patient within tuberculous peritoni

Serum CA 125 is of clinical value in the
โœ Mario Lazzarino; Ester Orlandi; Catherine Klersy; Cesare Astori; Ercole Brusamol ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 116 KB ๐Ÿ‘ 2 views

## Background: Ca 125 is a glycoprotein produced by epithelial ovarian tumors and by mesothelial cells; its levels also have been shown to be elevated in patients with non-hodgkin's lymphoma (nhl). ## Methods: The authors evaluated serum ca 125 levels in patients with nhl to elucidate the frequen